Brian Russell, Mba Email & Phone Number

San Diego, California, Us

San Diego, California, Us

• Drove negotiation of terms and successful contract completion for global animal health licensing rights to backup molecule of lead asset including a combination of cash and equity considerations• Provided financial analysis and term sheet advice on multiple offers leading to successful $54M+ Series A financing for spun-out radiopharmaceutical (Radionetics) company• Led and drove to go/no-go decisions multiple parallel strategic options for geographic expansion into China, incorporating clinical, commercial, and financial priorities into the sourcing and negotiating of several potential partnerships under a variety of deal structures• Managed key initiative exploring strategic commercial planning in Europe for two lead programs, encompassing country-by-country pricing and reimbursement landscapes, competitive landscape, and sequencing considerations• Asked by executive leadership to step into a global Program Team Lead position to shepherd a new preclinical program into IND-enabling activities• Spearhead corporate valuation process since inception several years ago and present final product to both executive and BOD audiences• Formed and lead cross-functional internal search & evaluation team to evaluate inorganic growth opportunities, including assessment of strategic fit and preparing presentations for Board and Executive governance review• Lead a team of six members of various seniority in multiple department initiatives including R&D strategy and planning, partnering outreach & external innovation, competitive intelligence, and new product planning

San Diego, California, Us

- Led full spectrum of deal activities to close licensing transaction for Japan rights to most advanced clinical asset. Coordinated cross-functional due diligence teams, collaborating across research and development, regulatory, finance, legal, and intellectual property.- Partnered with CEO to co-lead structuring and negotiations of corporate spin-out of discovery & preclinical radiopharmaceutical platform into Radionetics Oncology, a new company that simultaneously received $30M in funding from top-tier venture capital firms.- Direct early stage commercial opportunity assessments, conducting and incorporating market sizing, competitive landscape analysis, primary and secondary market research, and forecasting.- Actively working along the full continuum of drug development from discovery to late-stage clinical products with an awareness of commercial needs and differentiation.- Collaborate with R&D colleagues to develop program presentation material, with a strategic focus to maximize the value of the project.- Effectively managing and developing two PhD-level direct reports and regularly tasked with leading Corporate Strategy team-wide activities and initiatives.

Waltham, Ma, Us

Materially contribute to the origination, evaluation, and execution of both buy-side and sell-side bio-pharmaceutical strategic transactions. Coordinate and lead diligence to explore opportunities, assemble and present business cases to senior leadership, and offer analysis of competitive therapeutic landscapes from the financial and scientific perspectives while working closely and collaboratively with functional areas to identify and evaluate key risks and benefits in target areas and assets. Exemplary work-product, resourcefulness, flexibility, reliability, and a good sense of both the broad picture as well as the necessary attention to detail in a wide range of increasing responsibilities under the umbrella of pharmaceutical asset partnering.• Play an integral role in M&A, asset purchase, and licensing considerations, including, but not limited to, term sheet structuring and negotiation, diligence team coordination and interfacing with external parties, shepherding of definitive agreement process, presentation and consultation with the C-Suite on deal progress, and a primary contact for external financial advisors on deal activities. • Created a corporate forecast and valuation model with graphical dashboard to visualize current pipeline assets and liabilities, a synergies module for evaluating product acquisition opportunities, and cash-flow gap assessment to guide strategic decision making at the senior leadership level.• Advise on new product planning endeavors for early to mid-stage pipeline development as member of life cycle management teams, including presenting strategies and tactics to the C-Suite to support market development and portfolio planning. • Commission and manage contracted market research needs; including Awareness, Trial, Usage (ATU), Life Cycle Management (LCM), Patient Journey, and asset diligence campaigns.

Waltham, Ma, Us

• Spearheaded and drove to successful completion the sourcing, diligence, and negotiation of a contract for a commercial pharmaceutical product. The U.S. FDA Drug Shortage importation guidelines that governed the transaction added a layer of complexity. Development of internal and external relationships were paramount to the success of this project, including harnessing the help of company-wide department heads and the leadership skills necessary to successfully navigate the shifting priorities of those involved, including the C-Suite.• Critical core member of the company’s new technology strategic steering committee that stress-tests potential new asset acquisition and internal program readiness for integration into the corporate pipeline. Frequent diligence, particularly ownership around the areas of economic viability and valuation, market research, and freedom to operate are common contributions; as are presentations of findings to C-Suite and other senior leadership stakeholders.• Initiate and curate competitive intelligence platform with automated alerts, design and optimize opportunity tracking systems to ensure projects and ideas are progressing, provide a trusted source for ad-hoc analysis and presentations for C-Suite.

Carlsbad, California, Us

Drug development point-of-contact and public voice for corporate portfolio of R&D products and potential therapeutics while leading due diligence externally and internally, stress-testing new enterprise opportunities and engaging with leadership to identify high ROI project candidates, negotiating licensing opportunities, annual budgeting, market development and gap analysis that fulfill company objectives, and managing five direct reports.♦ Called upon by C-suite execs to regularly research and recommend new business and technology opportunities. Point-of-reference to evaluate in/out-licensing candidates and collaborators as well as internal project initiatives, craft and issue corporate communications, and consult on patent and regulatory filings.♦ Spearhead new enterprise assessment, particularly risk-reward analysis of new lines of product initiation and development.♦ Developed financial models for internal capital budgeting, new product forecasting, as well as therapeutic valuation for human and animal health therapies.♦ Entrusted with out-licensing the company’s drug portfolio including the lead chronic pain candidate.♦ Authored therapeutic alliance messaging to potential pharmaceutical partners and other executive audiences.

Carlsbad, California, Us

Liaised with executive team to align operations with corporate goals and lead project initiatives to increase the commercial top-line revenue contribution of R&D tools focused on Antibody Drug Conjugate (ADC) and neuroscience product areas.

Carlsbad, California, Us

Carlsbad, California, Us

Carlsbad, California, Us

Based on industry experience and broad management versatility, was selected from the staff at Advanced Targeting Systems to lay the groundwork for this start-up initiative on behalf of the CEO and President (advisory board investor/founders). Scope included messaging of value proposition, market assessment, asset valuation, and financing; requiring first hand knowledge and expertise with all the necessary drug development steps to formulate a strategy for the full life-cycle of the therapeutic pipeline.

Master Of Business Administration (M.B.A.)

Bachelor Of Science (B.S.), Animal Physiology And Neuroscience